Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
DemoEvolve: Overcoming Sparse Feedback in Agentic Harness Evolution with Demonstrations
arXiv:2605.24539v1 Announce Type: new Abstract: Agent harness evolution improves frozen language-model agents by modifying the executable structures around them. We study this paradigm as a form of sample-efficient fast adaptation: instead of updating model weights, an agent can acquire task-specific competence by changing its external harness, while leaving the base model's general capabilities intact. Prior work shows that self-generated rollouts can support harness search, suggesting that ag
-
cs.AI, q-bio.NC updates on arXiv.org
-
FileGram: Grounding Agent Personalization in File-System Behavioral Traces
arXiv:2604.04901v1 Announce Type: cross Abstract: Coworking AI agents operating within local file systems are rapidly emerging as a paradigm in human-AI interaction; however, effective personalization remains limited by severe data constraints, as strict privacy barriers and the difficulty of jointly collecting multimodal real-world traces prevent scalable training and evaluation, and existing methods remain interaction-centric while overlooking dense behavioral traces in file-system operations
FileGram: Grounding Agent Personalization in File-System Behavioral Traces
-
Omics In Lung
-
Artificial Intelligence for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer
J Inflamm Res. 2026 Mar 17;19:581764. doi: 10.2147/JIR.S581764. eCollection 2026.ABSTRACTImmune checkpoint inhibitors (ICIs) have significantly improved the clinical outcomes for patients with non-small cell lung cancer (NSCLC). However, patient heterogeneity and the limitations of current biomarkers contribute to variations in therapeutic responses. Identifying potential beneficiaries of immunotherapy and predicting efficacy remain critical challenges. In recent years, artificial intelligence (
Artificial Intelligence for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer
J Inflamm Res. 2026 Mar 17;19:581764. doi: 10.2147/JIR.S581764. eCollection 2026.
ABSTRACT
Immune checkpoint inhibitors (ICIs) have significantly improved the clinical outcomes for patients with non-small cell lung cancer (NSCLC). However, patient heterogeneity and the limitations of current biomarkers contribute to variations in therapeutic responses. Identifying potential beneficiaries of immunotherapy and predicting efficacy remain critical challenges. In recent years, artificial intelligence (AI) has become increasingly applied in cancer treatment, particularly for modeling clinical data and predicting patient prognosis. By integrating multi-omics data such as radiomics, pathomics, genomics, transcriptomics, proteomics, and microbiomics, AI enables comprehensive biomarker discovery and facilitates prediction of immunotherapy responses and potential toxicities in NSCLC patients. Despite these advancements, challenges such as data standardization, limited interpretability, and technical barriers persist. This review summarizes the application of AI in predicting immunotherapy efficacy for NSCLC patients and discusses the challenges and future directions in the context of precision medicine.
PMID:41867453 | PMC:PMC13005593 | DOI:10.2147/JIR.S581764
-
Nature - Issue - nature.com science feeds
-
Insulin resistance prediction from wearables and routine blood biomarkers
Nature, Published online: 16 March 2026; doi:10.1038/s41586-026-10179-2A machine-learning model that integrates data from wearable devices (such as smartwatches) with blood biomarkers and demographic data can predict whether someone has insulin resistance, enabling timely lifestyle interventions to prevent progression to type 2 diabetes.
Insulin resistance prediction from wearables and routine blood biomarkers
Nature, Published online: 16 March 2026; doi:10.1038/s41586-026-10179-2
A machine-learning model that integrates data from wearable devices (such as smartwatches) with blood biomarkers and demographic data can predict whether someone has insulin resistance, enabling timely lifestyle interventions to prevent progression to type 2 diabetes.-
cs.AI, q-bio.NC updates on arXiv.org
-
HEARTS: Benchmarking LLM Reasoning on Health Time Series
arXiv:2603.06638v1 Announce Type: cross Abstract: The rise of large language models (LLMs) has shifted time series analysis from narrow analytics to general-purpose reasoning. Yet, existing benchmarks cover only a small set of health time series modalities and tasks, failing to reflect the diverse domains and extensive temporal dependencies inherent in real-world physiological modeling. To bridge these gaps, we introduce HEARTS (Health Reasoning over Time Series), a unified benchmark for evalua